Clinical Trial Update: RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty [Phase 3]

View source ↗

Summary

Phase 3 RANGER trial comparing the paclitaxel-coated balloon (RANGER) to standard balloon angioplasty in peripheral artery disease has completed and results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Peripheral Artery Disease

Drugs mentioned

• RANGER Paclitaxel-Coated Balloon (paclitaxel-coated balloon)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Peripheral Artery Disease, Atherosclerosis | Phase 3 | Status: COMPLETED | Results posted: 2020-07-15